# Electroacupuncture for PHN: Efficacy and Biomarker Evaluation in a Multicenter, Randomized, Sham-Controlled Trial Protocol

> **NCT06990854** · NA · NOT_YET_RECRUITING · sponsor: **Dexiong Han** · enrollment: 207 (estimated)

## Conditions studied

- Postherpetic Neuralgia ( PHN )

## Interventions

- **DEVICE:** Electroacupuncture (Hans-100A, Nanjing Jisheng Medical Technology, China)
- **DRUG:** Pharmacotherapy：① Pregabalin ( Lyrica™ ，Pfizer Inc. America) ② Methylcobalamin ( Mecobalamin tablets， Weicai (China) Pharmaceutical Co., Ltd， China）
- **PROCEDURE:** Streitberger Placebo Needle Set ( Asiamed )

## Key facts

- **NCT ID:** NCT06990854
- **Lead sponsor:** Dexiong Han
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 207 (ESTIMATED)
- **Last updated:** 2025-07-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06990854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06990854, "Electroacupuncture for PHN: Efficacy and Biomarker Evaluation in a Multicenter, Randomized, Sham-Controlled Trial Protocol". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06990854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*